RAP 0.00% 20.5¢ raptor resources limited

Ann: Updated Top-line Results from SMARTCOUGH-C-2 Study, page-99

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 430 Posts.
    lightbulb Created with Sketch. 100
    I’d be very interested to see how the german hospital is handling croup diagnosis and if they are getting better outcomes and finding the App useful or if they are using a different method to the US. Eg is this a common theme or isolated in the US medical system,
    A different beneficial outcome in Germany as they are not running trials.

    Ce approval will get all 6 diseases but yet same app being used.
    Time to move on and focus on FDA Approval process, to look forward to some key areas

    The device does what it says it will do.
    Within given reasons the device is safe and effective.
    Scientific evidence to health, the benefits outweigh the risks.
    The device will help a large amount of the intended or targeted users.

    Not investment advice, do your own research, and consult a licensed adviser
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.